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Indications for Orthotopic Liver Transplantation: With 
Particular Reference to Hepatomas, Biliary Atresia, 
Cirrhosis, Wilson's Disease and Serum Hepatitis 
By T. E. STARZL, G. GILES, J. R. LILLY, H. TAKAGI, G. MARTINEAU, 
G. SCHROTER, C. G. HALGRIMSON, 1. PENN AND C. W. PUTNAM 
HEPATIC TRANSPLANTATION has passed 
through the feasibility stage of development 
since survival of humans for as long as 2~ 
years has been achieved following removal 
of the liver and its replacement (orthotopic 
transplantation) with a cadaveric homo-
graft. Consequently, the position will be 
taken that liver transplantation is a legiti-
mate albeit imperfect form of treatment. 
With this attitude, there is not a question 
about the propriety of clinical hepatic 
transplantation but only about the circum-
stances under which it should be consid-
ered. The opinions to be developed will be 
based primarily upon our own experience 
with orthotopic transplantation,1 although 
the reader is also referred to the important 
observations of Calne,2 Fortner et al.,3 and 
Birtch and Moore.4 
METHODS 
Thirty-three consecutive orthotopic liver re-
cipients, aged 11 months to 68 years, were treated 
from March 1963 to January 1970 by techniques 
described elsewhere.1 The first 25 cases were 
thoroughly documented in a recent book;1 the last 
eight have not been previously reported. In addi-
tion, a more recently treated patient will be men-
tioned briefly because of the specially interesting 
circumstances of treatment in the presence of 
Australia antigenemia. Immunosuppression of the 
first seven recipients was ,vith azatllioprine and 
prednisone. All subsequent patients were also 
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given heterologous antilymphocyte globulin 
(ALG). 
RESULTS 
Hepatoma 
The preoperative diagnosis of hepatoma 
was the reason for proceeding with the 
liver replacement of 12 of the 33 patients 
including six of the first eight. Six of these 
12 recipients had underlying cirrhosis of 
the Laennec, postnecrotic and biliary varie-
ties in three, two and one instances, re-
spectively. The biliary cirrhosis was in a 
10-year-old child with biliary atresia. An 
additional unsuspected small hepatoma was 
found in the liver of another child treated 
for intrahepatic biliary atresia, making a 
total of 13 cases available for observation. 
Early deaths. Seven of the 12 patients 
with prospectively diagnosed primary can-
cer of the liver died from 6~ to 39 days 
after orthotopic hepatic homotransplanta-
tion. Five of these cases were among the 
first seven in our experience; an important 
contributory cause of failure was the invari-
able use of livers that had been badly 
damaged by ischemia.1 The other two pa-
tients who were treated at a later time died 
of technical accidents with subphrenic 
abscesses and bile peritonitis, respectively. 
At autopsy, an exhaustive search was 
made to determine if any metastases had 
been missed with the preoperative survey 
and the operative examination. No residual 
tumor was found in 6 of the 7 recipients. 
In the other patients who died 7~ days after 
transplantation, there had been previously 
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Table I.-Fate of Six Patients Who Received Liver Replacement for Indication of Hepatoma and Lived 
Long Enough After Operation to Permit Observations About Course of Malignancy 
Patient Metastases 
Number First Location Metastases Organs 
Detected First Treatment of to Ultimately Cause of Death ( days postop. ) Metastases Metastases Homograft Involved & Time 
OT 8 90 Lungs Vincristine sulfate; Yes Brain., lungs, liver, other Carcinomatosis, 
5 FU; surgical exci- abdominal organs 400 days 
sion of intra abdomi-
nal masses; local Xray 
therapy to pelvis 
OT 14 380 Diaphragm, liver, Yes Mediastinum, pleural Carcinomatosis; dis-
retroperitoneal cavity, diaphragm, ruPted cholecyto-
space retroperitoneal space, duodenostomy,432 
liver, pancreas, other days" 
abdominal organs 
OT 15 60 Lungs Yes Lungs, liver, diaphragm Carcinomatosis, 
339 days 
OT 23 29 Lungs Yes Brain, lungs. liver Carcinomatosis, 
retroperitoneal space 143 days 
OT 26 59 Lungs No Lungs Gastrointestinal hem-
orrhage, 76 days 
OT 33 t None found Alive, 9 months 
.. Retransplantation had been carried out at 380 days, at which time the first metastases were discov-
ered. By the time of death 52 days later, the extension of the metastases was pronounced. 
t The diagnosis was an incidental finding in the liver specimen which had been removed because of 
biliary atresia. 
unsuspected spread to a lumbar vertebra. 
Prolonged survival. The other six: re-
cipients, including the one with an inci-
dental hepatoma, lived through the immedi-
ate effects of the operation and became 
available for longer term studies. In all six, 
hepatic cell carcinoma (hepatoma) was the 
histologic diagnosis. Five of the patients 
died 76, 143, 339, 400, and 432 days after 
operation (Table 1). Recurrent neoplasm 
was responsible for the death of four of the 
recipients. The fifth (OT 26) died of other 
causes but had developed a metastasis to 
the left lung. The most common sites of 
spread (Table 1) were the lungs and the 
liver homo grafts (four examples each). 
The only patient with hepatoma still sur-
viving is the 4-year-old girl with biliary 
atresia whose tumor was not known in ad-
vance to be present. In this case sera were 
examined by Dr. Elliot Alpert of the Peter 
Bent Brigham Hospital, Boston, for the 
presence of the fetoprotein which when 
found essentially always signifies the diag-
nosis of hepatoma.5 Fetoglobulin was found 
in the preoperative sample. Mter transplan-
t tation, the abnonnal protein persisted for 
\ 
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more than 5 months, but in diminishing 
quantities until it finally disappeared. The 
child is in excellent condition 9 months 
postoperative with no evidence of recur-
rence. 
Biliary Atresia 
There were 15 patients, aged 11 months 
to 5 years, with biliary atresia (13 extra-
hepatic and two intrahepatic), including 
the child whose excised liver was later dis-
covered to contain a small hepatoma. 
Early deaths. There were six: deaths 
within the first 40 postoperative days. These 
were caused by hepatic necrosis probably 
due to postmortem donor ischemia (two 
examples), thrombosis of the hepatic artery 
or portal vein (one example each), non-
thrombotic occlusion of the hepatic artery 
(one example), and generalized infection 
and pneumonia associated with partial 
biliary tract obstruction and cholangitis. 
Apart from the small size of the struc-
tures that had to be anastomosed, the 
atresia patients presented problems caused 
by a high incidence of anomalies. Three of 
the six early deaths listed above We1'e due 
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to technical accidents in patients who had 
anatomic variations including a hypoplastic 
portal vein, a fan-like hepatic arterial sup-
ply of diminutive host vessels too tiny to 
permit anastomosis, and a peculiar malrota-
tion in which the portal vein passed an-
terior to the duodenum. These and other 
anomalies which constitute a special hazard 
in recipients with biliary atresia have been 
described elsewhere.! 
Later deaths. Four of the nine patients 
who lived beyond 40 days died after 61, 
105, 133 and 186 days. All four deaths were 
caused by regional hepatic gangrene of 
which the essential cause was apparently 
too little immunosuppression. \Vith the cor-
rection of this defect in treatment and with 
attention to fixation of the liver to prevent 
distortion of the blood vessels,1 the compli-
cation of septic hepatic infarction was 
eliminated and has not been observed since 
November 1967. 
Three of the other five recipients are still 
alive after 9, 12, and 26 months. The two 
other children died after 13~ and 30 
months. The original homograft of both of 
these patients underwent slow rejection. In 
the first case, retransplantation was carried 
out after 68 days. The second transplant 
then supported life for a year before fail-
ing. The other child died 2~ years after a 
first orthotopic transplantation and 2)~ 
weeks after regrafting. The second trans-
plantation was greatly complicated by the 
fact that the portal and superior mesenteric 
veins had thrombosed and undergone ca-
vernous transformation. The immediate 
cause of death was bacterial peritonitis. 
Cirrhosis 
Six patients were treated, with the dis-
appointing record of five early deaths. Rea-
sons for the heavy acute mortality included 
the wretched condition of the recipients at 
the time of operation, major hemorrhage 
due to portal hypertension and the depres-
sion of normal coagulation, and technical or 
metabolic mishaps. 
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Alcoholic cirrhosis. Three patients aged 
33, 39, and 50 years died 10, 13 and 3 days 
respectively after operation. Obstruction of 
the homograft biliary drainage system had 
been accidentally produced in one recip-
ient. The second developed bile peritonitis 
after disruption of a choledochocholedocho-
stomy. The third suddenly became un-
conscious a few hours post-transplantation 
and never awakened; the cause for the 
neurologic calamity was not evident at 
autopsy. 
Postnecrotic cirrhosis. The two recipients, 
aged 8 and 15, had evidence after trans-
plantation of massive liver necrosis. They 
failed to wake from anesthesia and died 
after ~ and 9 days. 
Wilson's disease. The ll-year-old child 
was admitted in hepatic precoma. After 
liver replacement, he had a grave rejection 
crisis, the most severe one we have ever 
seen with recovery. His bilirubin rose to 
48.6 mg. per cent but eventually the process 
was reversed, so that now he has com-
pletely normal liver function 14 months 
later. A number of special studies are being 
reported by DuBois and his associates.6 
Briefly, the copper content of the excised 
liver was 216 f1.g./ Gm. wet tissue weight 
(normal less than 15 f1.g. ). The preoperative 
ceruloplasmin was 30 mg. per cent (low 
normal) and the urine copper 50 f1.g./24 
hours. 
After transplantation the ceruloplasmin 
rose to 40 mg. per cent. The urine copper 
increased to more than 300 f1.g./ 24 hours, 
before slowly returning to normal (less 
than 30 f1.g./ day) in the ensuing weeks. 
After 6 months, a homograft biopsy was 
obtained. The copper content was less than 
15 f1.g./Gm. wet tissue. 
The Question of Hepatitis 
Another case will now be recorded in ad-
dition to the 33 consecutive ones compiled 9 
months or longer ago. On August 8, 1970, 
a 28-year-old woman with chronic active 
hepatitis was treated with orthotopic liver 
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transplantation. For at least 2 years before 
operation and even on the day of liver re-
placement, immunodiffusion tests for the 
Australia antigen' had been positive. On 
the morning after operation, the Australia 
antigen had disappeared and it has not 
since heen found in any of the subsequent 
blood specimens. One month after opera-
tion, the patient has not had a rejection and 
is in excellent condition. 
DISCUSSIOK 
The main objective of this paper was to 
review the indications for orthotopic liver 
transplantation. Because of the high rate 
of recurrent carcinoma in our own ex-
perience, it has become policy in cases of 
hepatoma to consider liver replacement 
only under the most exceptional circum-
stances. This does not mean that some 
recipients with hepatoma cannot be cured 
nor does it imply criticism of other trans-
plantation groups who persist in similar 
therapeutic efforts. In fact, one of our 
recipients and one of CaIne's have no 
evidence at all of tumor recurrence and 
have probably been cured. 
Whatever the virtues and faults of liver 
replacement for hepatoma, by far the more 
desirable candidates for the procedures are 
those without neoplasms. On the average, 
the performance of orthotopic transplanta-
tion for benign disease is more difficult 
since the patients tend to be sicker and to 
have more advanced portal hypertension. 
Ivloreover, if the diagnosis is biliary atresia, 
an increased incidence of vascular anoma-
lies can be anticipated.1 Nevertheless, the 
longest survivors in the world after liver 
transplantation are patients who had biliary 
atresia. 
So far there have been few patients with 
cirrhosis who have bene:6.ted from liver 
transplantation. A reluctance to recommend 
such drastic therapy except in the agonal 
stages of the disease probably has been the 
main reason. Now that long-term survival 
and rehabilitation have been shown to be 
feasible, transplantation should be con-
sidered at an earlier time, particularly in 
cases of postnecrotic cirrhosis in which the 
maximum value of medical management 
and of abstinence from alcohol has already 
been realized. 
However, an important question must be 
answered in a number of such candidates 
concerning the cause for the progression of 
the hepatic disease. In the last 2 years, 
many patients with "chronic aggressive 
hepatitis" leading to fatal cirrhosis have 
had demonstrated in their serum the 
"hepatitis-associated" or Australia antigen. 
The existing evidence suggests that the 
Australia antigen is the actual serum 
hepatitis virus.7 If this were true, antirejec-
tion therapy could be predicted to per-
petuate and even aggravate the systemic 
virus infection by reducing host im-
munologic reactivity. 
The course of the patient whose Australia 
antigen test promptly became negative 
after liver replacement was decidedly 
against such pessimism, even though a 
follow-up is available for only a month. The 
immediate disappearance of the Australia 
antigen provided striking evidence for an 
essentially exclusive hepatic source of the 
antigenic factor, at least in the patient 
under discussion, whether this was the 
actual virus or something manufactured 
by the liver after induction by the virus. 
Observations of the child with Wilson's 
disease for 14 months after liver replace-
ment provided another example of the im-
portant ancillary information that has come 
from transplantation research. Insofar as 
can be determined in this recipient, an in-
born error of copper metabolism was cured 
by provision of a new liver. It is possible 
that further studv of this and similar cases 
will permit identincation of the basic defect 
in Wilson's disease and resolution of the 
controversies8 about its etiology. 
SUMMARY 
Orthotopic liver transplantation has led 
. 
\ 
\ 
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to prolongation of useful life. Among the 
first 33 recipients at the University of 
Colorado, there were eight who survided a 
year or longer, as well as a ninth who is 
in perfect health after nine months. The 
prime indication for orthotopic liver trans-
plantation is nonneoplastic hepatic disease. 
Treatment of hepatomas by liver replace-
ment has been followed by a high incidence 
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of tumor recurrence. 
As of November 16, 1970 the patient 
whose Au antigen became negative after 
transplantation had no difficulty for 2~ 
months. Then, the Au antigen became posi-
tive again and within a few days she de-
veloped clinical and laboratory evidence 
of acute hepatitis from which she is now 
recovering. 
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